Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran

Nephrology Dialysis Transplantation

Volumn 23, Issue 1, 2008, Pages 288-293

  Mahdavi Mazdeh, Mitra ^a,b   Zamyadi, Mahnaz ^c   Nafar, Mohsen ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON;

ADULT; AGED; ANEMIA; ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL PRACTICE; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INCIDENCE; IRAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TREATMENT RESPONSE; VASCULAR ACCESS; ADOLESCENT; CHILD; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; KIDNEY DISEASE; MIDDLE AGED; OUTCOME ASSESSMENT;

ADOLESCENT; ADULT; AGED; CHILD; CHRONIC DISEASE; FEMALE; HUMANS; IRAN; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RENAL DIALYSIS;

EID: 44449168114     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm580     Document Type: Article

References (30)

1. Modi GK, Jha V. The incidence of end-stage renal disease in India: a population-based study. Kidney Int 2006; 70: 2131-2133
2. Grassmann A, Gioberge S, Moeller S, Brown A. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 2005; 20: 2587-2593
3. Bamgboye EL. Hemodialysis: management problems in developing countries. Kidney Int 2003; 63: 93-95
4. Grassmann A, Gioberge S, Moeller S, Brown A. End-stage renal disease - global demographics in 2005 and observed trends. Artificial Organs 2006; 30: 895-898
5. Haghighi AN, Broumand B, D'amico M, Locatelli F, Ritz E. The epidemiology of end-stage renal disease in Iran in an international perspective. Nephrol Dial Transplant 2002; 17: 28-32
6. Mahdavi-Mazdeh M, Heidary RA, Norouzi Sh, Aghighi M, Rajolani H, Ahrabi S. Renal replacement therapy in Iran. Urol J 2007; 4: 66-70
7. Mahdavi-Mazdeh: Annual report of MCTSD - 2006 (RRT in Iran). Iranian J Urol (In press)
8. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006; 70: 1107-1114
9. Ghods AJ, Nasrollahzadeh D, Kazemeini M. Afghan refugees in Iran model renal transplantation program: ethical considerations. Transplant Proc 2005; 37: 565-567
10. Ayazi K, Atabak S, Saghebi R, Ayazi S, Aryasepehr S. Evaluation of efficacy, survival rate and complications of peritoneal catheter placement of patients with end-stage renal disease. Saudi Med J 2005; 26: 1391-1393
11. Shih YC, Guo A, Just PM, Mujais S. Impact of initial dialysis modality and modality switches on medicare expenditures of end-stage renal disease patients. Kidney Int 2005; 68: 319-329
12. Mircescu G, Garneata L, Florea L et al. The success story of peritoneal dialysis in Romania: analysis of differences in mortality by dialysis modality and influence of risk factors in a national cohort. Perit Dial Int 2006; 26: 266-275
13. Ghods A, Savaj Sh. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1: 1136-1145
14. Larijani B, Zahedi F, Taheri E. Deceased and living organ donation in Iran. Am J Transplant 2006; 6: 1493
15. Mendelssohn D, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Hemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006; 21: 721-728
16. Ortega T, Ortega F, Diaz-Corte C, Rebollo P, Ma Baltar J, Alvarez-Grande J. The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. Nephrol Dial Transplant 2005; 20: 598-603
17. Locatelli F, Pisoni RL, Combe CH, Bommer J, Andreucci VE et al. Anemia in hemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004; 19: 121-132
18. Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia. J Nephrol 2005; 18: 739-748
19. Yokoyama K, Katoh N, Kubo H et al. Clinical significance of the K/DOQI bone guidelines in Japan. Am J Kidney Dis 2004; 44: 383-384
20. Aly ZA, González EA, Martín KJ, Gellens ME. Achieving K/DOQI laboratory target values for bone and mineral metabolism: An uphill battle. Am J Nephrol 2004; 24: 422-426
21. Alavian SM, Einolahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology 2003; 8: 256-260
22. Einolahi B, Hajarizadeh B, Bakhtiari S et al. Pre-transplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 2003; 18: 836-840
23. Pedroso S, Martins L, Fonseca I et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc 2006; 38: 1890-1894
24. Fabrizi F, Bunnapradist S, Lunghi G, Martin P. Transplantation of kidneys from HCV-positive donors: a safe strategy? J Nephrol 2003; 16: 617-625
25. Karkar A. Hepatitis C in dialysis units: the Saudi experience. Hemodialysis Int 2007; 11: 354-367
26. Gallego E, Lopez A, Perez J et al. Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis'. Nephron Clin Pract 2006; 104: C1-C6
27. Maluf DG, Fisher RA, King AL et al. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 2007; 83: 853-857
28. Perico N, Plata R, Anabaya A et al. Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. Kidney Int 2005; 68 [Suppl 97]: S87-S94
29. Levey AS, Andreoli SP, Dubose T, Provenzano R, Collins AJ. Chronic kidney disease, common, harmful, and treatable - World Kidney Day 2007. Clin J Amer Soc Nephrol 2007; 2: 401-405
30. Prodjosudhadi W. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn Dis 2006; 16 [2 Suppl 2]: S14-S16